DEM Grand Rounds: March 2010

 

Thursday, March 4th

12:00 PM

Emergency Care In Haiti

Dr. McGeorge

E&R 2071 

1:00 PM

What Measures Of Disaster Management Planning Have Been Shown To Reduce Morbidity And Mortality?

Dr. Uebbing

E&R 2071 

2:00 PM

Suprventricular Tachycardia

Dr. Khan

E&R 2071 

3:00 PM

M&M

Dr. Kirkpatrick

E&R 2071 

4:00 PM

Chief Rounds

Dr. Kirkpatrick

E&R 2071 

Thursday, March 11th

12:00 PM

(30 min)

Esophageal Rupture

Dr. Davis

E&R 2071 

12:30 PM

(30 min)

Flexor Tenosynovitis

Dr. Leder

E&R 2071 

1:00 PM

Bites And Envenomations (Marine)

Dr. Folt

E&R 2071 

2:00 PM

ME Rounds

Dr. Hlavaty

E&R 2071 

3:00 PM

EBM

Dr. Goyal

E&R 2071 

4:00 PM

Medical Adventures

Dr. Martin

E&R 2071 

Thursday, March 18th

12:00 PM

Musculoskeletal Care Of Elderly Trauma Patients

Dr. Guthrie

E&R 2071 

1:00 PM

Do I Need To Gastric Lavage For Overdose?

Dr. Sullivan

E&R 2071 

2:00 PM

Ortho Small Group - Elbow Injuries

Dr. Nagarwala

E&R 2071 

3:00 PM

(2 hours)

Pediatrics

Dr. J Hays

E&R 2071 

6:00 PM

Journal Club

Dr. Hafez

Dr. Morris's Home 

Thursday, March 25th

12:00 PM

(5 hours)

Resident Retreat

Chief Residents

E&R 2071 

 

Last updated: 2-19-2010 11:03 AM

 

ACCREDITATION STATEMENT: Henry Ford Health System is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Henry Ford Health System takes responsibility for the content, quality, and scientific integrity of this CME activity. DESIGNATION STATEMENT: Henry Ford Health System designates this educational activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should claim credit commensurate with the extent of their participation in the activity. In the State of Michigan, Category 1 physician credits are applicable to nursing contact hours. FACULTY DISCLOSURE STATEMENT: All faculty and planning committee members participating in continuing education activities sponsored by Henry Ford Health System are required to disclose to the audience any relevant commercial relationships, and/or non-FDA approved use of a drug or a device that is included in the presentation.